Pursuant to Regulation 30 of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 we enclose herewith the summary of proceedings of the AGM.

$DARSHAII PHIRIIA IIIDU Head O?fice : 301, Aura Biplex, Premium Fletail Premi$e$, 7, S.V. Road, Borivali , Mumbai- 400092 E-mail: compliance@sudarshanpharma.com Websile: www.sudarshanpharma,com Board Line: +91-22-42221111 143331111 1422211'lS {100line)oQl1r| :151496MH2008P1C184997 l :l li.rirlil ;r . t1 ,, s Pt L/cs/s:tr.t2026.2027 161 Dale: 22nd September 2026 The Listing Department BSE Limited BSE Scrip Code. 543828 Phiroze Jeejeebhoy Towers, BSE Trading Symbol: SUDARSHAN Dalal Street, [Vlumbai - 400 001 lSlN: lNE00TV01023 Sub: Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Proceedings of 18th Annual General Meeting Dear Sir / N/adam, We inform you thatthe lBthAnnual General lMeeting ('AGM') of the Companywas held on Tuesday, 22nd September,2026 at 3.00 p.m. through Video Conferencing / Other Audio Visual IVIeans. Pursuant to Regulation 30 and Part A of Schedule Ill of the SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015, we enclose herewith the summary of proceedings of the AGIV. Request you to take the same on record Yours truly, For, Sudarshan Pharma lndustries Limited ', j irav Shah Company Secretary & Compl Officer t Encl: As above .;l,i Regd. Otf. : 301, Aura Biplex, Above Kalyan Jewellers, $,V. Road, Borivali {West), Mumbai - 40009?. PHfiRIII XUDTRXHIII IIIDIIiIRI.EE HD Head Otfice : 301, Aura Biplex, Premium Retail Premises, 7, S.V. Fload, Borivali (W: est), Mlumbai - 400092. E-mail : compliance@sudarshanpharma.com Website: wlwv.sudarshanpharma"com Board Line : +91-22-422211 1 1 / 43331 111 I 422211 t 6 (100 line) r Q|lr1 : 1514961i/H2008P1C184997 Summary of the proceedings of the 18th Annual General Meeting of Sudarshan Pharma lndustries Limited The 18th Annual General lVleeting ("AGM') of the members of Sudarshan Pharma lndustries Limited (the "Company") was held on Tuesday, 22nd September, 2026 a|3.00 p.in. throllgh Video Conferencing ("VC') / Other Audio Visual [Vleans ("OAVM') to transact the bqsiness'as setoutintheNoticeofAGtVldatedWednesday,12,nAugust,2026. [/r. Hemal [/lehta, Chairman & ft/anaging Director of the Company, chaired the AGIVI. The Chairman informed that the AG[/l was held through VC / OAVIVI in compliance with the circulars issued by the l/inistry of Corporate Affairs & Securities and Exchange Board of lndia. After ascertaining the requisite quorum, the Chairman called the AGIi/l to order. The Company Secretary introduced all the Directors present, Chief Financial Officer, Company Secretary.& Compliance Officer, Statutory Auditors and the Secretarial Auditors & Scrutinizer attending the AGIVI through VC / OAVIV The Chairman addressed the members, made his opening remarks with the overview of the present business and narrated the expansion & growth strategy. tt/r. Sachin lVehta, Joint lVlanaging Director informed the members about the financial performance of the Company & other operations during the financial year 2025-26. The Chairman's message, Notice of the 18th AG[M, Reports of the Directors and the Auditors and the Financial Statements for the financial year ended 31't [/larch, 2026, standalone and read. 'i ll consolidated, were taken as i' :il'r The Chairman informed the members about facility of e-voting provided by the Company to enable the members to cast their votes by electronic means, which shall continue to be available for 15 minutes after the conclusion of the AGIV. The Chairm.an informed the members that the Company has appointed Mr. Vishal [t/ansi!ta; Practicing Company $ecretary as the Scrutinizer to scrutinize the remote e-voting and e-voting at the AGIV'I in a fair and transparent manner. The following items of business as per Notice of the AGIV were transacted at the AGtr/ Sr. Details of the Agenda Resolution no. required To adopt the audited standalone financial statements (including Ordinary consolidated financial statements) of the Company for the financial year ended 31't lVarch,2026 together with the Reports of the Board of Directors and the Auditors thereon Regd. Otf. : 301, Aura Biplex, Above Kalyan Jewellers, $,V, Road, Borivali (West), Murnbai - 400092, PHIRIII XUDIR$HAII IIIDUXIRIEX LID Head Otfice : 301, Aura Biplex, Premium Hetail Premises, 7, S.V. Hoad, Borivali (West), hlurnbai - 400092 E-mail : compliance@sudarshanpharma.com Website: www.sudarshanpharma.com Board Line: +91-22-42221111 /43331111 142221116 (100|ine).911,1 :1514961r/H2008P1C184997 1 To appoint h director in place of Dr. Anil Ghogare (DtN - 00432659), Ordinary r L ,, who retires by rotation and being eligible, offers himself for .,. re-appointment The Chairman further informed the members that the consolidated results of the voting will be declared within two working days of the conclusion of the AGIVI upon receipt of the Scrutinizer's Report. The same shall be communicated to BSE Limited and also will be available on lhe Com pany's website www.sudarshanpharma. com The Chairman thanked the members for their continued support and for attending and participating in the AGIVI. He also thanked the Directors and other panellists for attending the AGIV. After conclusion of the voting process, the AGTVI ended with a vote of thanks to the Chair at 3.20 p m For, Sudarshan Pharma lndustri Limited Nh,bL Nirav Shah .' :, Company Secretary & Com Officer iLt rtlt ,rrr r l! r r:liltrt, Hegd. Off, : 301, Aura Biplex, Above Kalyan Jewellers, $.V, Hoad, Borivali (West), Mumbai - 400092.